Smoldering Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Smoldering Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients [Phase 2]
Phase 2 trial evaluating low-dose bortezomib for bone formation in patients with smoldering multiple myeloma; the study was terminated with …
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma [Phase 2]
A Phase 2 trial update on using celecoxib to prevent progression to multiple myeloma in patients with MGUS or smoldering myeloma; the study …
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma [Phase 2]
Phase II trial of Anti-KIR in smoldering multiple myeloma was terminated; results posted in 2015.
-
CLINICAL_TRIALS withdrawal · 2015-04-16Clinical Trial Update: Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma [Phase 2]
The Meir Medical Center-sponsored Phase 2 trial evaluating the efficacy and safety of a statin for progressive smoldering multiple myeloma h…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma [Phase 2]
Phase 2 trial evaluating green tea extract in patients with MGUS and/or smoldering multiple myeloma; the study was terminated with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of melphalan and bortezomib given before autologous stem cell transplant in multiple myeloma; the…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: A Trial of TBL12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma [Phase 2]
A Phase 2 trial evaluating TBL12 Sea Cucumber Extract in untreated asymptomatic myeloma was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Imaging in MGUS, SMM and MM [Phase 2]
Completed Phase 2 clinical trial evaluating imaging in monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and …
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma [Phase 2]
Phase 2 study evaluating IPH2101 in patients with smoldering multiple myeloma has completed; results were posted in May 2014.
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) [Phase 2]
A Phase 2 trial investigating prevention of disease progression in early-stage indolent B-cell malignancies (MGUS, smoldering multiple myelo…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression [Phase 3]
A Phase 3 study (QUIREDEX) evaluating lenalidomide plus dexamethasone versus observation in patients with smoldering multiple myeloma at hig…
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma [Phase 2]
Phase 2 trial evaluating anakinra with or without dexamethasone in patients with smoldering or indolent multiple myeloma; results were poste…